As the aging population continues to increase, aging-related
inflammation, oxidative stress, and
neurodegenerative diseases have become serious global health threats.
Resveratrol, a star molecule in natural
polyphenols, has been widely reported to have physiological activities such as anti-aging, anti-inflammatory,
antioxidant, and neuroprotection. However, its poor water solubility, rapid metabolism, low bioavailability and poor targeting ability, which limits its application. Accordingly, a brain-targeted
resveratrol liposome (ANG-RES-LIP) was developed to solve these issues. Experimental results showed that ANG-RES-LIP has a uniform size distribution, good biocompatibility, and a
drug encapsulation rate of over 90%. Furthermore, in vitro cell experiments showed that the modification of the targeting
ligand ANG significantly increased the capability of RES to cross the BBB and neuronal uptake. Compared with free RES, ANG-RES-LIP demonstrated stronger
antioxidant activity and the ability to rescue oxidatively damaged cells from apoptosis. Additionally, ANG-RES-LIP showed the ability to repair damaged neuronal mitochondrial membrane potential. In vivo experiments further demonstrated that ANG-RES-LIP improved cognitive function by reducing oxidative stress and
inflammation levels in the brains of aging model mice, repairing damaged neurons and glial cells, and increasing
brain-derived neurotrophic factor. In summary, this study not only provides a new method for further development and application of
resveratrol but also a promising strategy for preventing and treating age-related
neurodegenerative diseases.